• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值在接受放射性栓塞治疗的不可切除肝细胞癌患者中的预后作用

The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.

作者信息

Sukato Daniel C, Tohme Samer, Chalhoub Didier, Han Katrina, Zajko Albert, Amesur Nikhil, Orons Philip, Marsh James W, Geller David A, Tsung Allan

机构信息

Departments of Surgery.

Epidemiology.

出版信息

J Vasc Interv Radiol. 2015 Jun;26(6):816-24.e1. doi: 10.1016/j.jvir.2015.01.038. Epub 2015 Mar 29.

DOI:10.1016/j.jvir.2015.01.038
PMID:25824315
Abstract

PURPOSE

To assess the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients with unresectable intermediate- or advanced-stage hepatocellular carcinoma (HCC) treated with yttrium-90 radioembolization (RE).

MATERIALS AND METHODS

Retrospective chart review was performed for 176 patients with intermediate- or advanced-stage HCC treated with RE between August 2000 and November 2012. The appropriate NLR cutoff was determined by receiver operating characteristic curves. Demographic, clinical, radiographic, and pathologic parameters were compared between patients with a normal NLR (< 5) and those with an elevated NLR (≥ 5) before RE. Barcelona Clinic Liver Cancer (BCLC) stage-stratified univariate and multivariate analyses were conducted to determine variables associated with overall survival.

RESULTS

Under univariate analyses, patients with a normal NLR were found to have longer survival than individuals with a high NLR in intermediate/advanced-disease and advanced-disease cohorts. A multivariate Cox proportional-hazards model in the advanced-disease group confirmed that elevated NLR, high α-fetoprotein level, and low albumin level were independent predictors of worse survival.

CONCLUSIONS

This study provides stage-dependent evidence for the prognostic role of NLR in the radioembolized HCC cohort. Patients with BCLC stage C disease with elevated NLR may not derive benefit from RE, and other intervening modalities should be explored in this subpopulation.

摘要

目的

评估中性粒细胞与淋巴细胞比值(NLR)在接受钇-90放射性栓塞(RE)治疗的不可切除的中晚期肝细胞癌(HCC)患者中的预后价值。

材料与方法

对2000年8月至2012年11月期间接受RE治疗的176例中晚期HCC患者进行回顾性病历审查。通过受试者工作特征曲线确定合适的NLR临界值。比较RE治疗前NLR正常(<5)和NLR升高(≥5)的患者的人口统计学、临床、影像学和病理参数。进行巴塞罗那临床肝癌(BCLC)分期分层的单因素和多因素分析,以确定与总生存相关的变量。

结果

在单因素分析中,发现中晚期疾病和晚期疾病队列中NLR正常的患者比NLR高的患者生存时间更长。晚期疾病组的多因素Cox比例风险模型证实,NLR升高、甲胎蛋白水平高和白蛋白水平低是生存较差的独立预测因素。

结论

本研究为NLR在放射性栓塞HCC队列中的预后作用提供了分期依赖性证据。NLR升高的BCLC C期疾病患者可能无法从RE中获益,应在该亚组中探索其他干预方式。

相似文献

1
The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.中性粒细胞与淋巴细胞比值在接受放射性栓塞治疗的不可切除肝细胞癌患者中的预后作用
J Vasc Interv Radiol. 2015 Jun;26(6):816-24.e1. doi: 10.1016/j.jvir.2015.01.038. Epub 2015 Mar 29.
2
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.比较不可切除的肝细胞癌老年与年轻患者的放射性栓塞的生存和耐受性。
J Hepatol. 2013 Oct;59(4):753-61. doi: 10.1016/j.jhep.2013.05.025. Epub 2013 May 23.
3
How to select suitable hepatocellular carcinoma for liver transplantation by preoperative neutrophil-lymphocyte ratio.如何通过术前中性粒细胞与淋巴细胞比值选择合适的肝细胞癌进行肝移植
Hepatogastroenterology. 2014 Oct;61(135):2077-83.
4
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.钇 90 树脂微球放射栓塞治疗巴塞罗那临床肝癌各期肝癌的生存情况:欧洲评估。
Hepatology. 2011 Sep 2;54(3):868-78. doi: 10.1002/hep.24451. Epub 2011 Jun 30.
5
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.一种估算钇-90玻璃基放射性栓塞治疗后肝细胞癌所接受剂量的简单方法:概念验证研究的初步结果
J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007.
6
Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.428例接受放射性栓塞治疗的肝细胞癌患者分期系统的比较研究
J Vasc Interv Radiol. 2014 Jul;25(7):1056-66. doi: 10.1016/j.jvir.2014.01.010. Epub 2014 Mar 7.
7
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.在选择乙型肝炎病毒相关肝细胞癌肝移植候选者方面,将杭州标准与中性粒细胞与淋巴细胞比值相结合优于其他标准。
Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):588-95. doi: 10.1016/s1499-3872(15)60416-7.
8
Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.钇-90放射性栓塞治疗结直肠癌肝转移后生存的预测因素
J Vasc Interv Radiol. 2018 Aug;29(8):1094-1100. doi: 10.1016/j.jvir.2018.02.020. Epub 2018 May 10.
9
Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.放射性栓塞治疗伴门静脉侵犯的肝细胞癌的疗效:树脂微球与玻璃微球对比
J Vasc Interv Radiol. 2016 Jun;27(6):812-821.e2. doi: 10.1016/j.jvir.2016.01.147. Epub 2016 Apr 7.
10
Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.用于肝细胞癌的超选择性钇-90放射性栓塞术可产生高缓解率且毒性极小。
J Vasc Interv Radiol. 2014 Jul;25(7):1067-73. doi: 10.1016/j.jvir.2014.03.030. Epub 2014 May 14.

引用本文的文献

1
Immune Effects of Intra-Arterial Liver-Directed Therapies.经动脉肝脏靶向治疗的免疫效应。
J Vasc Interv Radiol. 2024 Feb;35(2):178-184. doi: 10.1016/j.jvir.2023.10.019.
2
Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.钇 90 微球选择性内放射治疗局部和局部进展期肝内胆管细胞癌。
Eur Radiol. 2024 Apr;34(4):2374-2383. doi: 10.1007/s00330-023-10203-3. Epub 2023 Oct 9.
3
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.
慢性病毒性肝炎对肝细胞癌炎症生物标志物预后价值的影响。
Cancer Med. 2021 Aug;10(16):5395-5404. doi: 10.1002/cam4.3573. Epub 2021 Jul 28.
4
Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma.基于炎症的标志物在肝细胞癌放射性栓塞治疗中的预后评估能力
Hepatoma Res. 2020;6. doi: 10.20517/2394-5079.2020.57. Epub 2020 Oct 12.
5
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict tumor size and survival in HCC patients: Retrospective study.血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值可预测肝癌患者的肿瘤大小及生存情况:一项回顾性研究
Ann Med Surg (Lond). 2020 Sep 6;58:167-171. doi: 10.1016/j.amsu.2020.08.042. eCollection 2020 Oct.
6
Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review.中性粒细胞与淋巴细胞比值和白蛋白-胆红素分级在肝细胞癌中的应用:一项系统综述。
World J Gastroenterol. 2020 Sep 7;26(33):5022-5049. doi: 10.3748/wjg.v26.i33.5022.
7
Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.免疫治疗与介入肿瘤学家:挑战与机遇——介入肿瘤学会白皮书。
Radiology. 2019 Jul;292(1):25-34. doi: 10.1148/radiol.2019182326. Epub 2019 Apr 23.
8
The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma.中性粒细胞与淋巴细胞比值及γ-谷氨酰转肽酶与血小板比值在肝细胞癌患者中的价值。
Medicine (Baltimore). 2019 Mar;98(9):e14749. doi: 10.1097/MD.0000000000014749.
9
Development of Atherosclerotic Cardiovascular Mortality in Gouty Arthritis and Rheumatoid Arthritis Patients: Are They Associated With Mean Platelet Volume and Neutrophil-Lymphocyte Ratio? A Comparative Study.痛风性关节炎和类风湿性关节炎患者动脉粥样硬化性心血管疾病死亡率的发展:它们与平均血小板体积和中性粒细胞-淋巴细胞比值有关吗?一项比较研究。
Arch Rheumatol. 2017 Feb 1;32(1):39-45. doi: 10.5606/ArchRheumatol.2017.6033. eCollection 2017 Mar.
10
Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study.PI3K通路突变与乳腺癌肝转移放射性栓塞后早期正电子发射断层扫描/计算机断层扫描成像反应的相关性:一项单中心回顾性初步研究结果
J Vasc Interv Radiol. 2018 Sep;29(9):1226-1235. doi: 10.1016/j.jvir.2018.04.018. Epub 2018 Aug 3.